Isolde and Emanuel lead units with fundamentally different business models that reflect their distinct market positions and strategic priorities. Isolde’s Siliquent operates in the B2B research equipment market, serving hospitals and laboratories with gene-based diagnostic tools. Her revenue model centers on equipment sales with a service-oriented approach—selling machines at cost while generating profits through ongoing support, maintenance, and regulatory compliance services. This model aligns perfectly with her market’s needs for customizable, high-touch solutions and reflects the complex, relationship-driven nature of the healthcare research sector. Emanuel’s Teomik targets a broader market of research institutions and universities, operating with a more traditional product-focused model. His approach emphasizes equipment sales as the primary revenue driver, with standardized offerings that maximize accessibility and market penetration. This model suits the academic market’s budget constraints and preference for straightforward purchasing arrangements, though it faces greater competitive pressure on margins.
The key difference lies in their value propositions: Isolde builds long-term service relationships that create recurring revenue and customer lock-in, while Emanuel focuses on volume sales and market share through competitive pricing. Both models are strategically sound for their respective markets, but they require different operational capabilities—Isolde needs strong service infrastructure and customer relationship management, while Emanuel requires efficient manufacturing and distribution systems. Rather than viewing these as competing approaches, the organization should recognize them as complementary strategies that serve different market segments effectively. The challenge lies in maintaining operational independence while capturing scale benefits where shared services truly create value.
In order to mediate a potential merger, I would set up a transparent, metrics-driven process to align Siliquent and Teomik without forcing a one-size-fits-all model. First, agree on shared objectives and decision criteria. These become the basis for trade-offs and direction on which approach to take. Second, create psychological safety: decouple strategy choices from job security through clear role protections and transition plans so leaders advocate honestly. Third, run parallel workstreams for (1) segment mapping, (2) product and roadmap mapping, and (3) GTM integration. This would help to compare each approach, and see along the way which aspects can be combined.
